⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CURI News
CuriosityStream Inc. Class A Common Stock
Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade Gliomas®
prnewswire.com
CURI
CuriosityStream Reiterates Q4 and Full-Year 2025 Outlook
accessnewswire.com
CURI
Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China
globenewswire.com
CURI
CuriosityStream to Participate at 28 th Annual Needham Growth Conference
businesswire.com
CURI
Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer USA - English USA - English
prnewswire.com
CURI
Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer
prnewswire.com
CURI
CuriosityStream to Participate at 14th Annual ROTH Deer Valley Event
businesswire.com
CURI
Curium Establishes Legal Entity in China
globenewswire.com
CURI
Curi Recognized as 2025 Wellbeing First Champion; First Medical Professional Liability Insurer To Receive Distinction
prnewswire.com
CURI
CuriosityStream Reports 46% Year-over-Year Revenue Increase
businesswire.com
CURI